Phase 3 Recruiting NIH
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
This phase III trial compares early treatment with venetoclax and obinutuzumab versus delayed treatment with venetoclax and obinutuzumab in patients with newly diagnosed high-risk chronic lymphocytic leukemia or small lymphocytic lymphoma.…
Sponsor: National Cancer Institute (NCI)
NCT ID: NCT04269902
Sites in Wyoming:
- Cheyenne Regional Medical Center-West — Cheyenne, Wyoming
- Billings Clinic-Cody — Cody, Wyoming
- Welch Cancer Center — Sheridan, Wyoming